Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
about
P1343
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomasMurine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapyTargeting heat shock protein 90 for the treatment of malignant pheochromocytomaCytocidal activities of topoisomerase 1 inhibitors and 5-azacytidine against pheochromocytoma/paraganglioma cells in primary human tumor cultures and mouse cell linesHigh-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paragangliomaAldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions.Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.Cell based therapy for the management of chronic pain.In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma.Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumorCharacterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging.Potential therapeutic target for malignant paragangliomas: ATP synthase on the surface of paraganglioma cellsAdditive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling PathwaysCharacterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature.Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytomaMitochondrial localization of human recombinant adenovirus: from evolution to gene therapyMicroCT for high-resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice.Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.A novel immunoprecipitation strategy identifies a unique functional mimic of the glial cell line-derived neurotrophic factor family ligands in the pathogen Trypanosoma cruzi.Adenoviral gene transfer in bovine adrenomedullary and murine pheochromocytoma cells: potential clinical and therapeutic relevanceAnti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cellsTyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models.Encapsulated pheochromocytoma cells secrete potent noncatecholamine factorsFamilial pheochromocytomas and paragangliomas.Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.Deletion of the synaptic protein interaction site of the N-type (CaV2.2) calcium channel inhibits secretion in mouse pheochromocytoma cellsPathology of Human Pheochromocytoma and Paraganglioma Xenografts in NSG MiceSignaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.The role of cell lines in the study of neuroendocrine tumors.Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model.Malignant pheochromocytoma: state of the field with future projections.Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.Animal models of pheochromocytoma including NIH initial experience.
P2860
Q24811594-EB8677E6-9EF9-48B3-B991-04A38AEE9166Q26828446-6BF5543F-A70C-412C-BC9A-812D84A80378Q28477147-ED685861-F8CA-4E4A-B1E9-75A0C80CC503Q28486170-47CAA43C-AB3A-4AA8-A92C-6A652B9314BAQ28539650-9B861D26-A0B9-42E7-83EA-483B21027E47Q28541862-4AD17C6A-D3DF-4DF0-980F-C7CB1C75AA0FQ33509010-A8EC2F48-FED0-4606-91D5-9AA073400655Q33585065-1C45E1BC-6075-439A-8F9F-FFDA33D6D6C0Q33638286-EBBFDC23-BC7B-44AF-B0E6-075C94818489Q33948942-E5FB1B49-1D3E-40A6-A292-A3B38D873C2FQ34580187-91BEEA68-E6D8-45FE-9A61-467D8635240DQ34636519-E31A8E1A-05EE-4A9E-8F37-FE10D84E6C2BQ34778752-CDE7CF5B-F058-45B8-877A-2039D8B38301Q35661386-239E4F53-DC97-45CA-8778-AB52AA79B635Q35758033-795BD000-8447-4A62-B936-16D64E51CF85Q35860831-5CF1C990-B6EA-42F8-8037-E7B54051E5D3Q36421897-1EB2E138-1AA2-4D09-A92C-FEFA353DA434Q36463116-D4971907-97D9-43DF-B581-96DD11F9C04EQ36517915-DFBBE229-D8CA-4636-9278-C408390CACDEQ36528860-7ED6778D-67E3-4750-8973-4F4614AAF832Q36629525-31F9906A-F1DB-4CA5-A9E2-86C284F4927FQ36804227-428B581A-B266-4D1E-A7BD-666701C434D3Q36856302-D04091BC-438B-4101-B300-6FE261699628Q36948906-BD693967-D5B2-45F9-8276-517CC02943E3Q37159039-9579F083-A3FF-44EF-BDAA-C64F37FEB3D7Q37315697-55223C5B-4CDF-42B0-BC3F-28A23288212DQ37360137-A084AA40-C074-4508-B82A-15461FF88412Q37457938-07429A91-024B-4439-B764-7C3C95B67226Q37471620-982D44B0-2C6F-4DF0-BF53-65B5B7E4D4D1Q37568369-0774F184-0B2E-444C-90D3-30841D265A39Q37580116-9BF625F9-6ED9-469B-9AF9-1D5024C4AF8BQ37589471-E33496E1-7B87-4FDC-BB8C-4F94366F5460Q37647258-AD8BDF07-E0C9-40B2-BE49-D95B7709B3FAQ37990768-12A1E0E5-B182-4A14-A58A-1FD8FF42D8D5Q38005913-599A84CD-B230-4858-8961-D13C3558A1BFQ39328101-635CEA9C-F4BA-4B20-BB08-28FEC56A9DADQ39428786-52F81A46-315D-4F7A-8D19-0FC8A9D051D2Q40270415-820ACEB0-08BA-41D2-ADC0-FC308183765BQ53060298-30B17BCB-94E1-46D7-A04C-1F85E109DD06Q53340022-F4D58BDB-4B85-43B0-A54A-5026169556C1
P2860
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
@en
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
@nl
type
label
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
@en
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
@nl
prefLabel
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
@en
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
@nl
P2093
P921
P356
P1476
Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.
@en
P2093
Evinger MJ
Shahsavari M
Tischler AS
P2888
P304
P356
10.1007/S004410000290
P4510
P577
2000-12-01T00:00:00Z